CNK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cinemark Holdings Inc (CNK) is not a strong buy at this time for a beginner investor with a long-term strategy. While there are some positive developments, such as hedge fund interest and a potential boost from the film slate in 2026, the company's recent financial performance and mixed analyst ratings suggest caution. The lack of strong proprietary trading signals and the neutral technical indicators further support a hold recommendation.
The MACD histogram is positive at 0.0576, indicating bullish momentum. The RSI is at 68.784, which is neutral but approaching overbought levels. Moving averages are converging, showing no clear trend. Key resistance is at 28.139, and support is at 24.354. Overall, the technical indicators suggest a neutral to slightly bullish trend.
Hedge funds are increasing their positions, with a 101.37% increase in buying activity last quarter.
Analysts from Roth Capital and MoffettNathanson have Buy ratings with price targets of $36 and $30, respectively, citing an improved film slate and margin expansion potential.
Paramount's potential acquisition of Warner Bros. could positively impact the competitive landscape for Cinemark.
Recent financial performance shows declining revenue (-4.67% YoY), net income (-33.46% YoY), and EPS (-20.59% YoY) in Q4
Mixed analyst ratings, with some firms maintaining Neutral or Sell ratings and price targets as low as $
The broader market (S&P
is down, reflecting a cautious sentiment.
In Q4 2025, revenue dropped to $776.3M (-4.67% YoY), net income fell to $33.8M (-33.46% YoY), and EPS declined to $0.27 (-20.59% YoY). However, gross margin slightly improved to 57.63%. Overall, financial performance indicates challenges in growth and profitability.
Analyst ratings are mixed. Some firms like Roth Capital and MoffettNathanson are optimistic, with Buy ratings and price targets of $36 and $30, respectively. Others, like Goldman Sachs and B. Riley, maintain Sell or Neutral ratings with lower price targets, citing challenges in sustaining market share and margin expansion.
